Astria Therapeutics ATXS
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 7.28 | 107.78 | -0.55 | -34,104 | -32 | |
| 2025Q2 | 5.36 | 108.37 | -0.57 | -35,820 | -33 | |
| 2025Q1 | 5.34 | 109.75 | -0.58 | -36,995 | -34 | |
| 2024Q4 | 8.94 | 115.47 | -0.44 | -29,591 | -26 | |
| 2024Q3 | 11.01 | 118.26 | -0.43 | -29,014 | -25 | |
| 2024Q2 | 9.10 | 119.16 | -0.43 | -28,803 | -24 | |
| 2024Q1 | 14.08 | 121.19 | -0.38 | -24,150 | -20 | |
| 2023Q4 | 7.68 | 108.88 | -0.94 | -34,199 | -31 | |
| 2023Q3 | 7.46 | 114.15 | -0.63 | -20,236 | -18 | |
| 2023Q2 | 8.33 | 120.18 | -0.45 | -15,102 | -13 | |
| 2023Q1 | 13.30 | 120.60 | -0.40 | -13,493 | -11 | |
| 2022Q4 | 14.89 | 107.74 | -0.64 | -14,290 | -13 | |
| 2022Q3 | 9.04 | 103.24 | -0.87 | -12,386 | -12 | |
| 2022Q2 | 3.00 | 101.76 | -0.86 | -11,449 | -11 | |
| 2022Q1 | 6.71 | 100.36 | -1.18 | -15,378 | -15 | |
| 2021Q4 | 5.39 | 100.18 | 3.23 | -9,508 | -9 | |
| 2021Q3 | 8.84 | 100.36 | 13.74 | -7,899 | -8 | |
| 2021Q2 | 100.24 | 4.05 | -7,484 | -7 | ||
| 2021Q1 | -45.60 | -170,085 | -170 | |||
| 2020Q4 | -2.64 | -8,978 | -9 |